Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-02 · accession 0001193125-25-308354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-04 | 2025-12-02+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $8.02 | +80.0K | 56.5K | New | +$641.4K |
| DMT | 2025-12-04 | 2025-12-02+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $145.66 | -80.0K | 7,229 | -92% | -$11.65M |
| DMT | 2025-12-04 | 2025-12-02+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -80.0K | 202.5K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | M | A | 10,558 | $8.02 | 17,787 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-03 | S | D | 20,163 | $146.94 | 7,229 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $142.66 and $148.39. |
| 3 | Common | Common Stock | 2025-12-03 | M | A | 20,163 | $8.02 | 27,392 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-02 | S | D | 49,252 | $144.59 | 7,229 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $141.79 and $149.23. |
| 5 | Common | Common Stock | 2025-12-02 | M | A | 49,252 | $8.02 | 56,481 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-04 | S | D | 10,558 | $148.18 | 7,229 | D | — | — | (F6) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $146.77 and $149.41. |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-12-03 | M | D | 20,163 | $0.00 | 182,382 | D | $146.94 · 2017-05-27 to 2026-05-27 | 20,163 Common Stock | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-12-04 | M | D | 10,558 | $0.00 | 171,824 | D | $148.18 · 2017-05-27 to 2026-05-27 | 10,558 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-12-02 | M | D | 49,252 | $0.00 | 202,545 | D | $144.59 · 2017-05-27 to 2026-05-27 | 49,252 Common Stock |